Use of plasma rich in growth factors (PRGF-Endoret®) fibrin membrane to cover corneal dellen.

Autor:	Rahhal-Ortuño M; Department of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain., Fernández-Santodomingo AS; Department of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain., Martínez-Rubio C; Department of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain., Barranco-González H; Department of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain., Almor-Palacios I; Department of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain., Rodrigo-Hernández A; Department of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Jazyk:	angličtina
Zdroj:	Romanian journal of ophthalmology [Rom J Ophthalmol] 2021 Jul-Sep; Vol. 65 (3), pp. 293-295.
DOI:	10.22336/rjo.2021.60
Abstrakt:	Corneal dellen appeared as a complication after perilimbal conjunctival papilloma dissection in a six-year-old patient. Our purpose was to describe the use of plasma rich in growth factors (PRGF) fibrin membrane in covering the corneal defect after conventional medical treatment failure. PRGF fibrin membrane is an interesting therapeutical option to consider not only in adult patients, but also in children. (© The Authors.Romanian Society of Ophthalmology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu